Corbus Pharmaceuticals Holdings, Inc. CRBP
CRBP
Corbus Pharmaceuticals Holdings, Inc. APLT
Applied Therapeutics, Inc. ELTX
Elicio Therapeutics, Inc. MOLN
Molecular Partners AG CRDF
Cardiff Oncology, Inc. RANI
Rani Therapeutics Holdings, Inc. MIST
Milestone Pharmaceuticals Inc. FBRX
Forte Biosciences, Inc. PEPG
PepGen Inc. IPHA
Innate Pharma S.A.
Corbus Pharmaceuticals Holdings, Inc. APLT
Applied Therapeutics, Inc. ELTX
Elicio Therapeutics, Inc. MOLN
Molecular Partners AG CRDF
Cardiff Oncology, Inc. RANI
Rani Therapeutics Holdings, Inc. MIST
Milestone Pharmaceuticals Inc. FBRX
Forte Biosciences, Inc. PEPG
PepGen Inc. IPHA
Innate Pharma S.A.
Performance
| Periode | CRBP | APLT | ELTX | MOLN | CRDF | RANI | MIST | FBRX | PEPG | IPHA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 9.31 % | -34.99 % | 0.00 % | 16.38 % | -43.99 % | 165.05 % | 50.57 % | 63.92 % | 280.00 % | -4.39 % |
| YTD | -16.11 % | -72.06 % | 56.03 % | -11.58 % | -43.47 % | 5.82 % | 21.43 % | -20.54 % | 51.19 % | 1.23 % |
| 1Y | -37.03 % | -79.26 % | 43.47 % | -23.52 % | -36.29 % | -18.68 % | 38.68 % | -14.59 % | 10.47 % | 5.17 % |
| 3Y | 169.33 % | -69.39 % | 36.16 % | -35.73 % | 79.72 % | -80.47 % | -33.29 % | -17.77 % | -60.00 % | -13.95 % |
| 5Y | -74.49 % | -98.92 % | 36.16 % | -78.09 % | -87.46 % | -85.95 % | -65.60 % | -97.78 % | -55.78 % | -64.68 % |
| 10Y | -79.09 % | -97.33 % | 36.16 % | -78.09 % | -99.37 % | -85.95 % | -82.86 % | -99.57 % | -55.78 % | -68.71 % |
| From the beginning | -88.78 % | -97.33 % | 36.16 % | -78.09 % | -99.85 % | -85.95 % | -82.86 % | -99.57 % | -55.78 % | -68.71 % |